KLSE (MYR): HUMEIND (5000)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
3.60
Today's Change
+0.04 (1.12%)
Day's Change
3.53 - 3.63
Trading Volume
1,355,200
Market Cap
2,612 Million
NOSH
725 Million
Latest Quarter
31-Mar-2024 [#3]
Announcement Date
15-May-2024
Next Quarter
30-Jun-2024
Est. Ann. Date
24-Aug-2024
Est. Ann. Due Date
29-Aug-2024
QoQ | YoY
3.39% | 126.07%
Revenue | NP to SH
1,202,540.000 | 209,047.000
RPS | P/RPS
165.76 Cent | 2.17
EPS | P/E | EY
28.81 Cent | 12.49 | 8.00%
DPS | DY | Payout %
6.58 Cent | 1.83% | 22.85%
NAPS | P/NAPS
0.80 | 4.49
QoQ | YoY
19.46% | 757.45%
NP Margin | ROE
17.38% | 35.92%
F.Y. | Ann. Date
31-Mar-2024 | 15-May-2024
Latest Audited Result
30-Jun-2023
Announcement Date
04-Oct-2023
Next Audited Result
30-Jun-2024
Est. Ann. Date
04-Oct-2024
Est. Ann. Due Date
27-Dec-2024
Revenue | NP to SH
1,014,281.000 | 60,034.000
RPS | P/RPS
139.81 Cent | 2.57
EPS | P/E | EY
8.28 Cent | 43.50 | 2.30%
DPS | DY | Payout %
0.00 Cent | 0.00% | 0.00%
NAPS | P/NAPS
0.59 | 6.15
YoY
1825.4%
NP Margin | ROE
5.92% | 14.13%
F.Y. | Ann. Date
30-Jun-2023 | 24-Aug-2023
Revenue | NP to SH
1,252,417.333 | 224,604.000
RPS | P/RPS
172.63 Cent | 2.09
EPS | P/E | EY
30.96 Cent | 11.63 | 8.60%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
4.58% | 766.53%
NP Margin | ROE
17.93% | 38.59%
F.Y. | Ann. Date
31-Mar-2024 | 15-May-2024
Trailing 4 Quarters | Trailing 8 Quarters | |||
---|---|---|---|---|
Available Quarters | 4 Quarters | 8 Quarters | ||
Continuous Quarters Of Revenue Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Total Positive Profit Years | 4 / 4 | 100.00% | 7 / 8 | 87.50% |
Continuous Quarters Of Positive Profit | 4 / 4 | 100.00% | 6 / 8 | 75.00% |
Continuous Quarters Of Profit Growth | 4 / 4 | 100.00% | 6 / 8 | 75.00% |
Continuous Quarters Of Adjusted EPS Growth | 4 / 4 | 100.00% | 6 / 8 | 75.00% |
Total Dividend Years | 2 / 4 | 50.00% | 2 / 8 | 25.00% |
Continuous Quarters Of Dividend | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
Continuous Quarters Of Dividend Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Adjusted Dps Growth | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
Average ROE | 10.70% | 6.12% | ||
Average Net Profit Margin | 17.30% | 9.60% |
Last 5 Financial Years | Last 10 Financial Years | |||
---|---|---|---|---|
Available Years | 5 Years | 10 Years | ||
Continuous Quarters Of Revenue Growth | 3 / 5 | 60.00% | 3 / 10 | 30.00% |
Total Positive Profit Years | 2 / 5 | 40.00% | 5 / 10 | 50.00% |
Continuous Quarters Of Positive Profit | 2 / 5 | 40.00% | 2 / 10 | 20.00% |
Continuous Quarters Of Profit Growth | 4 / 5 | 80.00% | 4 / 10 | 40.00% |
Continuous Quarters Of Adjusted EPS Growth | 4 / 5 | 80.00% | 4 / 10 | 40.00% |
Total Dividend Years | 0 / 5 | 0.00% | 3 / 10 | 30.00% |
Continuous Quarters Of Dividend | 0 / 5 | 0.00% | 0 / 10 | 0.00% |
Continuous Quarters Of Dividend Growth | 0 / 5 | 0.00% | 0 / 10 | 0.00% |
Continuous Quarters Of Adjusted Dps Growth | 0 / 5 | 0.00% | 0 / 10 | 0.00% |
Average ROE | -5.39% | -4.30% | ||
Average Net Profit Margin | -4.29% | -2.15% |
T4Q | Annualized | Annual (Unaudited) | Last 10 FY Average | Last 5 FY Average | |
---|---|---|---|---|---|
Revenue | 1,202,540 | 1,252,417 | 1,014,281 | 599,177 | 713,482 |
NP to SH | 209,047 | 224,604 | 60,034 | -4,910 | -21,651 |
Dividend | 47,761 | 66,749 | 0 | 3,832 | 0 |
Adjusted EPS | 28.81 | 30.96 | 8.28 | -0.78 | -3.45 |
Adjusted DPS | 6.58 | 9.20 | 0.00 | 0.61 | 0.00 |
NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share
All figures in '000 unless specified.
EPS & DPS's figures in Cent.
LQ QoQ | LQ YoY | CQ YoY | LQ vs Average of T4Q | LQ vs Average of T8Q | |
---|---|---|---|---|---|
Revenue | -3.68% | 7.41% | 25.07% | 3.25% | 14.60% |
NP to Owner | 3.39% | 126.07% | 766.53% | 16.84% | 109.28% |
Dividend | 0.00% | 0.00% | 0.00% | 214.45% | 528.90% |
Adjusted EPS | 3.39% | 126.07% | 766.53% | 16.84% | 109.28% |
Adjusted DPS | 0.00% | 0.00% | 0.00% | 214.45% | 528.90% |
LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year
T4Q vs LFY | T4Q vs AL5FY | T4Q vs AL10FY | AQR vs LFY | AQR vs AL5FY | AQR vs AL10FY | LFY YoY | LFY vs AL5FY | LFY vs AL10FY | |
---|---|---|---|---|---|---|---|---|---|
Revenue | 18.56% | 68.55% | 100.70% | 23.48% | 75.54% | 109.02% | 39.61% | 42.16% | 69.28% |
NP to Owner | 248.21% | 1,065.52% | 4,356.97% | 274.13% | 1,137.37% | 4,673.77% | 1,825.40% | 377.28% | 1,322.51% |
Dividend | 0.00% | 0.00% | 1,146.14% | 0.00% | 0.00% | 1,641.55% | 0.00% | 0.00% | 0.00% |
Adjusted EPS | 248.21% | 1,065.52% | 4,356.97% | 274.13% | 1,137.37% | 4,673.77% | 1,825.40% | 377.28% | 1,322.51% |
Adjusted DPS | 0.00% | 0.00% | 1,146.14% | 0.00% | 0.00% | 1,641.55% | 0.00% | 0.00% | 0.00% |
T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year
I think cement theme almost over alr la, last year alr run so much
2024-01-04 03:29
@wahidul, seems like macam yes wor, but don't you think the share price rally last year alr factor in some of the positive news?
2024-01-09 12:39
Construction and building material materials will be the theme to play in 2024.. don’t miss the ride.. jump in now or never
2024-01-10 20:00
With so much development in coming years, cement business will prosper for quite some time. Mce and Hume still got much more room for growth..
2024-01-12 09:37
guys.. now or never.. it is the construction related theme to rock this year and I believe the Humeind will be the "chosen one".. TP 5.4
2024-01-18 09:50
Are you sure troy88? Your call has been pretty accurate so far but I think the rally is running out of steam
2024-01-24 11:18
MCEMENT T4Q Result: ( EPS: 27.39, P/E: 17.96 ) price at $4.92
HUME T4Q Result: ( EPS: 27.86, P/E: 9.08 ) so, I am waiting HUME at $4.92 with pe18...
OK!!
2 months ago
Using 4 rolling quarters, the EPS of Mcement and Humeind is 27.34 sen and 27.85 sen respectively.
In term of fair valuation, I believe EPS of Humeind is still better than Mcement.
CIMB gives a target price of Mcement at 6.80, using the same method of calculation, the fair target price of Humeind should be 6.93.
The current share price of Humeind is 3.12, there is a potential gain of 122%.
Cement stock will perform very well in the next 2 to 3 years due to MRT, LRT, ECRL, other infrastructure projects and data centers construction.
Good luck.
Thank you.
1 month ago
MCEMENT PE 20 , HUME PE 9?
MCEMENT profit margin 10% , HUME profit margin 19.6%
It doesn't make sense
1 month ago
HLIB can recommend Mcement, but cannot recommend Humeind.
CGS recommended Mcement the target at 6.80, but did not recommend Humeind.
So far no investment bank recommends Humeind, hence Humeind cannot perform.
I also agreed that Humeind is really undervalued.
Need to wait for Mcement result to be released, then may be Humeind can perform.
Good luck.
Thank you.
1 month ago
Humeind will continue to break a new high because the earning of Humeind is better than Mcement in term of EPS.
The share price Humeind is chasing the share price of Mcement which is far ... far ... ahead.
Good luck.
Thank you.
----------------------------
Using 4 rolling quarters, the EPS of Mcement and Humeind is 27.34 sen and 27.85 sen respectively.
In term of fair valuation, I believe EPS of Humeind is still better than Mcement.
CIMB gives a target price of Mcement at 6.80, using the same method of calculation, the fair target price of Humeind should be 6.93.
The current share price of Humeind is 3.12, there is a potential gain of 122%.
Cement stock will perform very well in the next 2 to 3 years due to MRT, LRT, ECRL, other infrastructure projects and data centers construction.
Good luck.
Thank you.
1 month ago
Still underrated despite stellar earnings for the past few QRs and positive outlook..
1 month ago
The Q3 2024 result of Humeind released is considered as very good if compared to Mcement.
HLIB can recommend Mcement, but cannot recommend Humeind (sister company).
CGS recommended Mcement, the target at 6.80, but did not recommend Humeind.
RHB recommended MCement, the target price at 7.15, but did not recommend Humeind.
So far no investment bank recommends Humeind, hence the share price of Humeind cannot perform.
I also agreed that Humeind is really undervalued.
The present share price at 3.40 is still considered as a cheap share if compared against Mcement.
Good luck.
Thank you.
1 month ago
Comparing with mcement is good due to similar business lines, but to note that share price is reflective of future earnings and potential and not purely current earnings, therefore has to be seen with a pinch of salt. Hong Leong Group has its own version of high PER company as well for example MPI, with current PER of 90!!! Therefore this share price is cheap is not fully true....
1 month ago
Uniholder
Fire up to 2.25 ushering new year can ah ? 🔥🔥😁
2023-12-21 21:15